Introduced:
Jul 23, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
4
Actions
12
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Jul 23, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Actions (4)
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Jul 23, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Jul 23, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
Jul 23, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
Jul 23, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (11 of 12)
(D-CA)
Oct 10, 2025
Oct 10, 2025
(D-OR)
Aug 19, 2025
Aug 19, 2025
(D-DC)
Aug 15, 2025
Aug 15, 2025
(D-TN)
Aug 8, 2025
Aug 8, 2025
(D-IN)
Aug 8, 2025
Aug 8, 2025
(D-MI)
Aug 8, 2025
Aug 8, 2025
(D-NJ)
Aug 8, 2025
Aug 8, 2025
(D-CA)
Aug 8, 2025
Aug 8, 2025
(R-FL)
Jul 23, 2025
Jul 23, 2025
(R-IA)
Jul 23, 2025
Jul 23, 2025
(D-WA)
Jul 23, 2025
Jul 23, 2025
Showing latest 11 cosponsors
Full Bill Text
Length: 7,106 characters
Version: Introduced in House
Version Date: Jul 23, 2025
Last Updated: Nov 15, 2025 2:12 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4752 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 4752
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 23, 2025
Ms. Wasserman Schultz (for herself, Mrs. Miller-Meeks, Ms. Schrier, and
Mr. Buchanan) introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[H.R. 4752 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 4752
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 23, 2025
Ms. Wasserman Schultz (for herself, Mrs. Miller-Meeks, Ms. Schrier, and
Mr. Buchanan) introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Reducing Hereditary Cancer Act''.
SEC. 2.
HISTORY OF A HEREDITARY CANCER GENE MUTATION OR PERSONAL
OR FAMILY HISTORY SUSPICIOUS FOR HEREDITARY CANCER.
(a) Coverage.--
OR FAMILY HISTORY SUSPICIOUS FOR HEREDITARY CANCER.
(a) Coverage.--
Section 1861 of the Social Security Act (42 U.
1395x) is amended--
(1) in subsection
(s)
(2) --
(A) by striking ``and'' at the end of subparagraph
(II) ;
(B) by striking the period and inserting ``; and''
at the end of subparagraph
(JJ) ; and
(C) by inserting after subparagraph
(JJ) the
following new subparagraph:
``
(KK) in the case of an individual with a personal
or family history of a hereditary cancer gene mutation
or a personal or family history suspicious for
hereditary cancer, germline mutation testing.''; and
(2) by adding at the end the following new subsection:
``
(nnn) Germline Mutation Testing.--The term `germline mutation
testing' means genetic testing for germline mutations that is in
accordance with evidence-based, clinical practice guidelines
specifically addressing genetic testing, screening, and management of
individuals with inherited mutations associated with increased cancer
risk that--
``
(1) have been developed by a nationally recognized
oncology professional organization, including the National
Comprehensive Cancer Network, the American Society of Clinical
Oncology, the Society of Gynecologic Oncology, or any other
oncology professional organization specified by a medicare
administrative contractor with a contract under
(1) in subsection
(s)
(2) --
(A) by striking ``and'' at the end of subparagraph
(II) ;
(B) by striking the period and inserting ``; and''
at the end of subparagraph
(JJ) ; and
(C) by inserting after subparagraph
(JJ) the
following new subparagraph:
``
(KK) in the case of an individual with a personal
or family history of a hereditary cancer gene mutation
or a personal or family history suspicious for
hereditary cancer, germline mutation testing.''; and
(2) by adding at the end the following new subsection:
``
(nnn) Germline Mutation Testing.--The term `germline mutation
testing' means genetic testing for germline mutations that is in
accordance with evidence-based, clinical practice guidelines
specifically addressing genetic testing, screening, and management of
individuals with inherited mutations associated with increased cancer
risk that--
``
(1) have been developed by a nationally recognized
oncology professional organization, including the National
Comprehensive Cancer Network, the American Society of Clinical
Oncology, the Society of Gynecologic Oncology, or any other
oncology professional organization specified by a medicare
administrative contractor with a contract under
section 1874A;
and
``
(2) in the case of conflicting guidelines developed by
more than one nationally recognized oncology professional
organization, the least restrictive of such guidelines, as
determined by such a medicare administrative contractor.
and
``
(2) in the case of conflicting guidelines developed by
more than one nationally recognized oncology professional
organization, the least restrictive of such guidelines, as
determined by such a medicare administrative contractor.''.
(b) Frequency.--
``
(2) in the case of conflicting guidelines developed by
more than one nationally recognized oncology professional
organization, the least restrictive of such guidelines, as
determined by such a medicare administrative contractor.''.
(b) Frequency.--
Section 1862
(a)
(1) of the Social Security Act (42
U.
(a)
(1) of the Social Security Act (42
U.S.C. 1395y
(a)
(1) ) is amended--
(1) by striking ``and'' at the end of subparagraph
(O) ;
(2) by adding ``and'' at the end of subparagraph
(P) ; and
(3) by adding at the end the following new subparagraph:
``
(Q) in the case of germline mutation testing as
defined in
section 1861
(lll) , which is performed more
than once with respect to an individual described in
such section;''.
(lll) , which is performed more
than once with respect to an individual described in
such section;''.
(c) Effective Date.--The amendments made by this section shall
apply to testing furnished on or after the date of the enactment of
this Act.
than once with respect to an individual described in
such section;''.
(c) Effective Date.--The amendments made by this section shall
apply to testing furnished on or after the date of the enactment of
this Act.
SEC. 3.
(a) In General.--
Section 1862 of the Social Security Act (42 U.
1395y) is amended by adding at the end the following new subsection:
``
(p) Coverage of Certain Risk-Reducing Surgeries.--In the case of
an individual described in
``
(p) Coverage of Certain Risk-Reducing Surgeries.--In the case of
an individual described in
section 1861
(s)
(2)
(II) for whom, based on
evidence-based, clinical practice guidelines described in
(s)
(2)
(II) for whom, based on
evidence-based, clinical practice guidelines described in
section 1861
(lll) , surgery would reduce the risk of developing cancer, such
risk-reducing surgery shall be considered reasonable and necessary for
treatment of illness under subsection
(a)
(1)
(A) .
(lll) , surgery would reduce the risk of developing cancer, such
risk-reducing surgery shall be considered reasonable and necessary for
treatment of illness under subsection
(a)
(1)
(A) .''.
(b) Effective Date.--The amendment made by subsection
(a) shall
apply to items and services furnished on or after the date of the
enactment of this Act.
risk-reducing surgery shall be considered reasonable and necessary for
treatment of illness under subsection
(a)
(1)
(A) .''.
(b) Effective Date.--The amendment made by subsection
(a) shall
apply to items and services furnished on or after the date of the
enactment of this Act.
SEC. 4.
HEREDITARY CANCER GENE MUTATION.
(a) In General.--
(a) In General.--
Section 1862 of the Social Security Act (42 U.
1395y), as amended by
section 3, is amended by adding at the end the
following new subsection:
``
(q) Coverage of Evidence-Based Screenings for Individuals With a
Hereditary Cancer Gene Mutation.
following new subsection:
``
(q) Coverage of Evidence-Based Screenings for Individuals With a
Hereditary Cancer Gene Mutation.--In the case of an individual who is
determined pursuant to genetic testing to have a hereditary cancer
(germline) gene mutation, the Secretary shall increase any frequency
limitations (or other limitations on coverage otherwise applicable
under this title) for any evidence-based screenings furnished to such
individual, to be in compliance with evidence-based, clinical practice
guidelines described in
``
(q) Coverage of Evidence-Based Screenings for Individuals With a
Hereditary Cancer Gene Mutation.--In the case of an individual who is
determined pursuant to genetic testing to have a hereditary cancer
(germline) gene mutation, the Secretary shall increase any frequency
limitations (or other limitations on coverage otherwise applicable
under this title) for any evidence-based screenings furnished to such
individual, to be in compliance with evidence-based, clinical practice
guidelines described in
section 1861
(lll) , or as determined appropriate
by the Secretary, but not less frequently than on an annual basis.
(lll) , or as determined appropriate
by the Secretary, but not less frequently than on an annual basis. For
the purposes of this subsection, evidence-based screenings shall
include screening mammography, breast screening MRI, colonoscopy, PSA
testing, and any additional evidence-based screening modalities
appropriate for high-risk individuals as recommended by such
guidelines.''.
(b) Conforming Amendment for Screening Mammography.--
by the Secretary, but not less frequently than on an annual basis. For
the purposes of this subsection, evidence-based screenings shall
include screening mammography, breast screening MRI, colonoscopy, PSA
testing, and any additional evidence-based screening modalities
appropriate for high-risk individuals as recommended by such
guidelines.''.
(b) Conforming Amendment for Screening Mammography.--
Section 1834
(c) (2)
(A) of the Social Security Act (42 U.
(c) (2)
(A) of the Social Security Act (42 U.S.C. 1395m
(c) (2)
(A) ) is
amended, in the matter preceding clause
(i) , by striking ``subparagraph
(B) '' and inserting ``subparagraph
(B) and
(A) of the Social Security Act (42 U.S.C. 1395m
(c) (2)
(A) ) is
amended, in the matter preceding clause
(i) , by striking ``subparagraph
(B) '' and inserting ``subparagraph
(B) and
section 1862
(q) ''.
(q) ''.
(c) Effective Date.--The amendments made by this section shall
apply to items and services furnished on or after the date of the
enactment of this Act.
<all>